December 19, 2025 16:15 ET | Source: Zenas BioPharma WALTHAM, Mass., Dec. 19, 2025 (GLOBE NEWSWIRE) -- Zenas BioPharma, Inc.…
December 12, 2025 16:30 ET | Source: Zevra Therapeutics CELEBRATION, Fla., Dec. 12, 2025 (GLOBE NEWSWIRE) -- Zevra Therapeutics, Inc.…
HANGZHOU, China, Nov. 26, 2025 /PRNewswire/ -- The BMW Group has officially granted licenses for two of its micromobility concepts…
November 21, 2025 09:00 ET | Source: InspireMD Inc. MIAMI, Nov. 21, 2025 (GLOBE NEWSWIRE) -- InspireMD, Inc. (Nasdaq: NSPR)…
Vancouver, BC, Nov. 07, 2025 (GLOBE NEWSWIRE) -- Rocket Doctor AI Inc. (CSE: AIDR, OTC: AIRDF, Frankfurt: 939) (“Rocket Doctor…
In Canada, lecanemab is indicated for the treatment of adult patients with a clinical diagnosis of mild cognitive impairment or…
October 10, 2025 16:41 ET | Source: Crinetics Pharmaceuticals, Inc. SAN DIEGO, Oct. 10, 2025 (GLOBE NEWSWIRE) -- Crinetics Pharmaceuticals,…
October 10, 2025 16:05 ET | Source: Vera Therapeutics BRISBANE, Calif., Oct. 10, 2025 (GLOBE NEWSWIRE) -- Vera Therapeutics, Inc.…
October 03, 2025 16:05 ET | Source: Spyre Therapeutics, Inc. WALTHAM, Mass., Oct. 03, 2025 (GLOBE NEWSWIRE) -- Spyre Therapeutics,…
October 03, 2025 16:01 ET | Source: Intellia Therapeutics, Inc. CAMBRIDGE, Mass., Oct. 03, 2025 (GLOBE NEWSWIRE) -- Intellia Therapeutics,…